MedPath

Evaluating the effect of L-carnitine on CK-MB and troponin T value following coronery artery bypass grafting (CABG) surgery

Not Applicable
Conditions
Atherosclerotic heart disease.
Atherosclerotic heart disease
Registration Number
IRCT201404268698N13
Lead Sponsor
Tehran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

The patients who candidate for Coronary artery bypass graft surgery in Tehran Heart center are selected by simple randomised method; There are not any limitations for age; and sex in this study. Exclusion criteria: Valvular surgery; History of supraventricular arrhythmia; History of siezure; History of hypersensitivity reaction to l-carnitine; Chronic liver failure (Liver enzymes more than 3 times of ULN); Chronic kidney disease (Stage IV & V); Hypothyroidism; Use of Magnesium, NSAIDs and Antiarrhythmic medication, history of myocardial infarction within 1 month of hospitalization

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial fibrillation. Timepoint: 5 days post CABG surgery. Method of measurement: ECG, CK-MB.
Secondary Outcome Measures
NameTimeMethod
Atrial fibrillation. Timepoint: 5 days post CABG surgery. Method of measurement: Troponin T.
© Copyright 2025. All Rights Reserved by MedPath